Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

18 Sep 2024 15:00

RNS Number : 7429E
B.P. Marsh & Partners PLC
18 September 2024
 

18 September 2024

 

B.P. Marsh & Partners Plc

PDMR and Director Dealing

 

B.P. Marsh (AIM: BPM), the specialist investor in early-stage financial services businesses, announces that it has been notified that Ms. Alice Foulk, Managing Director of the Company, has traded in the ordinary shares of 10 pence each in the Company ("Ordinary Shares")

 

The Company has been notified of the sale of Ordinary Shares on 17 September 2024 at the open market price of 526.32p per share by Ms. Alice Foulk, Managing Director of the Company. The Ordinary Shares sold were held under the B.P. Marsh Joint Share Ownership Plan (the "JSOP") ("JSOP Shares").

 

The JSOP was established on 13 June 2018 and announced by the Company on the same date. On this date the Employee Participants entered into individual Joint Ownership Agreements ("JOAs") with JTC Employer Solutions Trustee Limited (formerly RBC cees Trustee Limited) (the "EBT") as part of the Company's remuneration and staff incentive arrangements.

 

The beneficial interests in the JSOP Shares are jointly held between the relevant employee and the EBT. The terms of the JOA included a minimum vesting period of three years and, subject to the Employee Participant remaining employed for this duration, state that upon sale of the vested shares the proceeds of sale will be divided between the joint owners so that the EBT receives 312.60p per share (which represents the Initial Threshold Value of 281p plus a hurdle amount of 3.75% per annum during the vesting period) and the Employee Participant is entitled to the balance of 213.72p per share. The JOAs matured as fully vested on 13 June 2021 and Ms. Foulk has now partially exercised her right to sell 27,200 JSOP Shares.

 

As a result of the transaction, Alice has a beneficial interest in 23,428 Ordinary Shares, together with a beneficial interest in 25,809 Ordinary Shares held in the Company's SIP Trust, representing in aggregate approximately 0.13% of the total voting rights of the Company.

 

Additionally, Alice, as part of the Company's Joint Share Ownership Plan, has a beneficial interest (as a joint owner alongside JTC Employer Solutions Trustee) over 90,414 Ordinary Shares, representing approximately 0.24% of the total voting rights of the Company.

 

Furthermore, Alice has options over 260,000 Ordinary Shares as part of the Company's Share Option Plan announced on 15 November 2023.

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alice Foulk

2

Reason for notification

a)

Position / status

Managing Director, PDMR

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Sale of interests in shares pursuant to a Joint Share Ownership Plan for 526.32p per share. On sale of a JSOP Share, the participant is entitled to the sale proceeds in excess of a threshold amount of 312.6p. An Employee Benefit Trust is entitled to the balance of the sale proceeds.

c)

Price(s) and volumes(s)

 

Price(s)

£5.2632 per share

Volume(s)

27,200

d)

Aggregated information

N/A

e)

Date of the transaction

2024-09-17

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker

Panmure Liberum Limited

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Joint Corporate Broker

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

Financial PR & Investor Relations

 

 

+44 (0)20 7496 3000

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for over ten years.

 

- Ends -

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDCUUBDGSI
Date   Source Headline
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:01 amRNSFinal Results for the Year to 31 January 2026
27th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of Results and Investor Presentation
24th Apr 20265:50 pmRNSTransaction in Own Shares
20th Apr 20265:25 pmRNSSIP Awards, PDMR Dealings, Treasury Shares, TVR
16th Apr 20267:00 amRNSDeferred Consideration Receipt & Special Dividend
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSFollow-on equity purchase in Pantheon
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20263:52 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSNew Share Buyback Programme
18th Mar 20267:00 amRNSNew Investment: Nine Edge Wealth Limited
18th Mar 20267:00 amRNSNew Investment: Ventura Risk Partners Holdings
17th Mar 20264:48 pmRNSSale of Interest in Amiga to Sodalis
11th Mar 20267:00 amRNSUpdate on Sodalis Capital Limited
24th Feb 20267:00 amRNSTrading Update
6th Feb 20267:00 amRNSPurchase of Own Shares and Total Voting Rights
5th Feb 202611:44 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSInterim Dividend Declaration
18th Dec 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
15th Dec 20257:00 amRNSSpecial Dividend Declaration
11th Dec 20257:00 amRNSAppointment of Nominated Adviser and Joint Brokers
2nd Dec 20257:00 amRNSChange in Executive Directorship Roles
27th Nov 20256:17 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSNew Investment: Sodalis Capital Limited
25th Nov 20254:55 pmRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:57 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202512:38 pmRNS-RB.P. Marsh to present at MelloLondon
11th Nov 20255:08 pmRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:01 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSSale of Stewart Specialty Risk Underwriting
27th Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSHalf-year Results
7th Oct 202511:15 amRNSNotice of HY Results and Investor Presentation
30th Sep 20253:52 pmRNSNew Investment: Oneglobal Broking Holdings Limited
23rd Sep 20257:00 amRNSTrading Update
22nd Sep 20253:23 pmRNSNew Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.